01—Abstract
Summary
Summary of the 10-K filed June 14, 2002. Cited figures are marked; the original filing is the authoritative source.
Symantec Corporation reported net revenues of $1.07 billiona for fiscal 2002 (year ended March 31, 2002), up 26% from $853.6 million in fiscal 2001.
The company swung to a net loss of $28.2 millionb, or $0.20 per share, compared with net income of $63.9 million in fiscal 2001. Operating income fell to $8.0 million from $109.6 million, driven mainly by $196.8 million of goodwill amortization from the December 2000 AXENT Technologies acquisition, along with $20.4 million of restructuring, site closure and other expenses and a $3.1 million litigation judgment charge. Enterprise Security was the largest segment at $454.9 million, or 42% of revenues, up 61% from fiscal 2001, while Consumer Products rose to $376.1 million, or 35% of revenues.
Management stated that consumer antivirus growth in the second half of fiscal 2002 may not be sustained and that enterprise security sales declined from the third to the fourth quarter. The balance sheet was strengthened by the October 2001 private offering of $600.0 millionc of 3% convertible subordinated debentures due November 1, 2006, with net proceeds of approximately $584.6 million. Cash, cash equivalents and short-term investments totaled $1.38 billion at March 31, 2002, compared with $557.0 million a year earlier.
Stockholders' equity was $1.32 billiond against total assets of $2.50 billion. Operating cash flow was $511.2 million. The company repurchased $204.4 million of stock during the year and completed a two-for-one stock split effected as a stock dividend on January 31, 2002.
Beginning April 1, 2002, Symantec will stop amortizing goodwill under SFAS No. 142. The filing states this is expected to increase results by approximately $198.4 million in fiscal 2003, excluding potential impairment charges, and that operating results may become more volatile due to periodic goodwill impairment tests. The company also disclosed pending patent and copyright litigation and a planned relocation of its Leiden, Netherlands operations to Dublin, Ireland.
02—Key points
Key Highlights
- Net revenues rose 26% to $1,071.4 million in fiscal 2002, driven by Enterprise Security and a significant increase in consumer product sales in the second half of the year.
- Net loss of $28.2 million, or $(0.20) per share, versus net income of $63.9 million in fiscal 2001, reflecting $196.8 million of goodwill amortization and $20.4 million of restructuring charges.
- Enterprise Security revenue reached $454.9 million (42% of total net revenues), up 61%, with a full year of AXENT product sales.
- Issued $600.0 million of 3% convertible subordinated debentures due 2006 in October 2001, with net proceeds of approximately $584.6 million.
- Cash, cash equivalents and short-term investments of $1,375.1 million at March 31, 2002, up from $557.0 million a year earlier.
- Goodwill amortization ends April 1, 2002 under SFAS No. 142; the filing expects this to increase fiscal 2003 results by about $198.4 million before any impairment charges.
- Management cautioned that consumer antivirus sales growth may not be sustained and that enterprise security sales declined from the third to the fourth quarter of fiscal 2002.
03—Questions
Frequently Asked Questions
Why did Symantec swing from a profit to a loss in fiscal 2002 despite higher revenue?
Net revenues grew 26% to $1,071.4 million, but operating income fell to $8.0 million from $109.6 million. The main drivers were goodwill amortization of $196.8 million, mostly from the AXENT acquisition, and restructuring, site closure and other expenses of $20.4 million. The effective tax rate on pre-tax income was 162%, reflecting non-deductible goodwill amortization, which produced a net loss of $28.2 million.
How will the change in goodwill accounting affect future earnings?
Effective April 1, 2002, net goodwill of approximately $521.9 million will no longer be amortized. The filing states this is expected to increase fiscal 2003 results by approximately $198.4 million, excluding potential impairment charges. Results may become more volatile because of periodic goodwill impairment charges.
What are the main risks to the consumer business?
Management said growth in consumer antivirus sales in the second half of fiscal 2002 was higher than expected and may not be sustained. It attributed the strength partly to the Code Red and Nimda outbreaks and to reactions to the September 11 attacks, and said these factors are likely to weaken over time. The filing also noted that the release of Windows XP may have spurred sales, and that Microsoft and other operating system vendors adding security features could reduce demand.
What obligations did the company take on to fund its growth?
The company issued $600.0 million of 3% convertible subordinated debentures due November 1, 2006, convertible at $34.14 per share, and reserved approximately 17.6 million common shares for conversion. It also has synthetic lease arrangements for facilities in Cupertino, California, Newport News, Virginia, and Springfield, Oregon, with cash collateral of approximately $124.3 million restricted at March 31, 2002. Total contractual obligations were $686.1 million, including the debentures and $86.1 million of operating leases.
What pending legal matters could affect results?
The company accrued $3.1 million in the March 2002 quarter for post-judgment interest and costs on a Canadian copyright judgment inherited through the Delrina acquisition. Other pending matters include a patent suit by Altiris, a PowerQuest partitioning patent claim against Quarterdeck, and a Hilgraeve patent suit that was returned to the District Court in September 2001. Management stated that the outcome of these cases is not expected to have a material adverse effect on financial condition, but unfavorable resolutions could materially affect results in a particular period.
04—Continue